Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders
Clinical Reviews in Allergy & Immunology,
Journal Year:
2025,
Volume and Issue:
68(1)
Published: Feb. 11, 2025
Language: Английский
Revealing the viral culprits: the hidden role of the oral virome in head and neck cancers
Archives of Microbiology,
Journal Year:
2025,
Volume and Issue:
207(4)
Published: Feb. 28, 2025
Abstract
The
oral
viral
microbiome
(or
virome),
encompassing
a
diverse
community
of
viruses
within
the
cavity,
has
emerged
as
significant
yet
underexplored
factor
in
head
and
neck
cancers
(HNCs).
This
review
synthesizes
recent
evidence
linking
virome
to
carcinogenesis,
particularly
oropharyngeal
nasopharyngeal
carcinomas—the
most
common
virus-associated
subtypes
HNCs.
Beyond
pathogenesis,
diagnostic
therapeutic
implications
are
explored,
including
non-invasive
salivary
detection
biomarkers
for
early
cancer
diagnosis,
development
targeted
antiviral
therapies,
preventive
vaccination
strategies—exemplified
by
success
HPV
vaccines
reducing
incidence
cancers.
Despite
these
advancements,
challenges
persist,
technical
limitations,
need
longitudinal
studies,
integration
multi-omics
approaches.
A
comprehensive
understanding
could
revolutionize
diagnostics,
therapeutics,
prevention.
Moving
forward,
collaborative
interdisciplinary
efforts
will
be
essential
fully
leverage
research
improving
HNC
outcomes.
Language: Английский
Metachronous Occurrence of Epstein-Barr Virus-Positive Mucocutaneous Ulcers Suspected to be Related to Periodontitis: A Case Report
Yukiko Kusuyama,
No information about this author
Rie Irie,
No information about this author
Atsuko Niki-Yonekawa
No information about this author
et al.
Journal of Oral and Maxillofacial Surgery Medicine and Pathology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
Language: Английский
Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report
Pathogens,
Journal Year:
2025,
Volume and Issue:
14(5), P. 488 - 488
Published: May 16, 2025
Background:
This
case
is
unique
in
demonstrating
the
reactivation
of
latent
tuberculosis
(TB)
following
co-infection
with
SARS-CoV-2
and
Epstein–Barr
virus
(EBV)
an
otherwise
healthy
young
adult.
It
highlights
a
rare
clinical
scenario
which
viral
immune
dysregulation
likely
facilitated
TB
progression.
To
date,
few
reports
have
explored
complex
interplay
between
COVID-19,
EBV
reactivation,
single
patient,
particularly
isolated
extrapulmonary
involvement.
Case
Presentation:
A
24-year-old
woman
presented
persistent
low-grade
fever,
fatigue,
night
sweats,
unintentional
weight
loss,
progressive
cervical
supraclavicular
lymphadenopathy.
These
symptoms
emerged
shortly
after
moderate
COVID-19
infection.
Laboratory
studies
revealed
elevated
inflammatory
markers
pronounced
lymphopenia.
was
confirmed
via
serology
PCR.
Despite
antiviral
therapy,
persisted,
imaging
necrotic
Tuberculous
lymphadenitis
diagnosed
through
fine-needle
aspiration
cytology
PCR
detection
Mycobacterium
tuberculosis.
The
patient
treated
standard
anti-tuberculosis
regimen,
resulting
clinical,
radiological,
immunological
improvement.
Conclusions:
underscores
importance
considering
patients
lymphadenopathy
recent
infections,
regions
high
prevalence.
also
emphasizes
need
for
thorough
microbiological
assessment
post-viral
syndromes.
main
takeaway
that
may
create
permissive
environment
system
compromise.
Language: Английский
Insights into the complexities of Citrullination: From immune regulation to autoimmune disease
Jiawei Wang,
No information about this author
Jinlin Miao,
No information about this author
Ping Zhu
No information about this author
et al.
Autoimmunity Reviews,
Journal Year:
2024,
Volume and Issue:
unknown, P. 103734 - 103734
Published: Dec. 1, 2024
Language: Английский
The Functional Interaction Between Epstein–Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma
Cancers,
Journal Year:
2024,
Volume and Issue:
16(24), P. 4212 - 4212
Published: Dec. 18, 2024
The
Epstein–Barr
virus
(EBV)
is
associated
with
a
wide
range
of
diseases,
malignant
and
non-malignant.
EBV
was,
in
fact,
the
first
described
cell
transformation
capacity,
discovered
by
Epstein
1964
lymphoma
samples
from
African
children.
Since
then,
has
been
several
human
tumors
including
nasopharyngeal
carcinoma,
gastric
T-cell
lymphoma,
Hodgkin
diffuse
large
B
Burkitt
among
others.
molecular
hallmark
(BL)
chromosomal
translocation
that
involves
MYC
gene
immunoglobulin
loci,
resulting
deregulated
expression
MYC,
an
oncogenic
transcription
factor
appears
about
half
tumors.
role
well
established,
as
overexpression
drives
proliferation
through
multiple
mechanisms,
foremost,
stimulation
cycle.
Indeed,
found
overexpressed
or
non-Hodgkin
lymphomas.
Most
endemic
many
sporadic
BLs
are
infection.
While
some
mechanisms
which
can
contribute
to
BL
have
reported,
mechanism
links
infection
still
under
debate.
Here,
we
review
main
EBV-associated
special
focus
on
BL,
discuss
interaction
during
BL.
Language: Английский